Source:http://linkedlifedata.com/resource/pubmed/id/15245516
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-7-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0902-4441
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15245516-Cytogenetic Analysis,
pubmed-meshheading:15245516-Humans,
pubmed-meshheading:15245516-Male,
pubmed-meshheading:15245516-Middle Aged,
pubmed-meshheading:15245516-Piperazines,
pubmed-meshheading:15245516-Primary Myelofibrosis,
pubmed-meshheading:15245516-Pyrimidines,
pubmed-meshheading:15245516-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Successful treatment of advanced idiopathic myelofibrosis with imatinib mesylate.
|
pubmed:publicationType |
Letter
|